Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jacob, Zaemes"'
Autor:
Samir Gupta, Michael B Atkins, Neil J Shah, Jacob Zaemes, Shaked Lev Ari, Yili Zhang, Adil Alaoui, Subha Madhavan, Peter McGarvey
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/a4c1b501eb1d4b51a05770744fdfed2a
Autor:
Samir Gupta, Michael B Atkins, Meredith Regan, Neil J Shah, Jacob Zaemes, Opeyemi A Jegede, Shaked Lev Ari, Lauren Pascual, Natali Arias-Orozco, Brittany Sinclaire, Alexandra DellaPia, Rachel A Zemel, Yili Zhang, Adil Alaoui, Andrew Ip
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/543f662ef85345d892a18d4460b414d0
Autor:
Michael B Atkins, Neil J Shah, Jacob Zaemes, Andrew Pecora, Shaked Lev Ari, Lauren Pascual, Brittany Sinclaire, Alexandra DellaPia, Rachel A Zemel, Adil Alaoui, Andrew Ip, Deniz Ozisik, Ming Tan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/330e36ff912446ba91242d45a6d6e317
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Large-cell neuroendocrine carcinoma (LCNEC) is a rare subtype of non-small-cell lung cancer associated with a poor prognosis. LCNEC is genetically heterogeneous, and studies have revealed distinct molecular subtypes of LCNEC, which may have therapeut
Externí odkaz:
https://doaj.org/article/6333e38bba694d93b859d532e5152abf
Autor:
Jong Kun Park, Ilan Vavilin, Jacob Zaemes, Araba Ofosu-Somuah, Raghav Gattani, Camila Sahebi, Alexander G. Truesdell
Publikováno v:
Cardiovascular Innovations and Applications, Vol 7, Iss 1, p 980 (2023)
Background: Spontaneous heparin-induced thrombocytopenia is a pro-thrombotic syndrome in which anti-heparin antibodies develop without heparin exposure. Case presentation: A 78-year-old man who underwent a successful lumbar laminectomy presented to t
Externí odkaz:
https://doaj.org/article/1d822b1b71f847adaafb974ec61567dc
Autor:
Michael B. Atkins, Suthee Rapisuwon, Arash Radfar, Kellie Gardner, Neil J. Shah, Geoffrey T. Gibney, Jacob Zaemes, Shelly Shand, David Swoboda, Vesna Petronic-Rosic, Michael J. Reilly, Waddah B. Al-Refaie
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/da787bd08d4c48ef8ac5864ccea25a5d
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Cytokine release syndrome (CRS) is a well-described immune-related adverse event following chimeric antigen receptor T-cell therapy, but has rarely been reported following anti-programmed death ligand-1 therapy. We report the case of a 55-year-old ma
Externí odkaz:
https://doaj.org/article/5fb6b65bcb1145da8e5ec2dbe9e18865
Publikováno v:
Immune Checkpoint Inhibitors-New Insights and Recent Progress ISBN: 9781803565903
Immune Checkpoint Inhibitors-New Insights and Recent Progress
Immune Checkpoint Inhibitors-New Insights and Recent Progress
The management of hepatocellular carcinoma (HCC) has been transformed by the incorporation of immune checkpoint inhibitor therapy. Compared to traditional chemotherapy, these regimens have markedly improved outcomes in patients with HCC. Additionally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abcd55fbbd9f5f73e9a3f048911f2135
https://doi.org/10.5772/intechopen.107097
https://doi.org/10.5772/intechopen.107097
Publikováno v:
Immunotherapy. 12:861-867
Background: Despite the profound effect that checkpoint inhibitors and BRAF/MEK inhibitors have had on survival in patients with metastatic melanoma, treatment options remain limited for those who demonstrate poor response or develop resistance to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1839f7c668cd7746681bd89d24a25dd8
https://doi.org/10.2217/imt-2020-0139
https://doi.org/10.2217/imt-2020-0139
Autor:
Jacob Zaemes, Chul Kim
Publikováno v:
European Journal of Cancer. 132:168-175
Background An amassing body of evidence exists to support an association between the use of immune checkpoint inhibitors (ICIs) and the development of tuberculosis (TB). Methods We performed a systematic review of the literature to assess the nature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b8cd541d6adefe6e96f557c6e7a139f
https://doi.org/10.1016/j.ejca.2020.03.015
https://doi.org/10.1016/j.ejca.2020.03.015